Jakob Knudsen, Chief Executive Officer

Jakob assumed his role as CEO in April 2011.

jacob knudsenJakob was previously CCO & CFO of Egalet Ltd. a Danish based biotech company focusing on development of pain products. Jakob oversaw all commercial operations including IP and Financing and was responsible for entering into 8 commercial collaborations (licensing and feasibility stage agreements). In addition Jakob closed several rounds of financing and also the transition of the business from a Danish legal entity into the UK legal entity.

Prior to this Jakob was heading the Corporate Business Development function at ALK-Abelló A/S, a Danish biopharmaceutical company. Jakob was responsible for ALK’s deals for its allergy tablet portfolio and over his 9 year tenure, was involved with ALK’s acquisitions made over the years with target companies in Switzerland, France, New York and a joint venture in Germany.

Jakob was responsible for setting up ALK-Abelló’s Chinese subsidiary and he also took part in the processes to independently list ALK on the Copenhagen Stock Exchange. Jakob has additionally held responsibility for various sales and marketing functions.

Jakob is a lawyer by training and trained with the law-firm Arup & Hvidt in Copenhagen. He also holds an MBA from Imperial College, UK.

May Britt Dyvelkov, Chief Financial Officer

May Britt assumed her role as CFO in November 2008.

may brittMay Britt have been working in finance her entire career. She has been in leading financial positions for several IT companies, most recently as CFO of the Icelandic IT reseller Kerfi A/S (since 2001). Prior to joining Kerfi she held the position of CFO in EET Nordic for 6 years. May has been creating financial systems and implemented them to fit companies growing from 7 to 70 employees, and has been part of several mergers and acquisition.   

Contact us

virogates logo2
Blokken 45

3460 Birkerød

Phone +45 21 13 13 36
Skype: virogates
CVR No.: 25734033

 in-2  tw-2